Not finding it? Sign in to also search OpenAlex live.
-
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT
Avichai Shimoni, Marie Robin, Simona Iacobelli, Dietrich Wilhelm Beelen, Ghulam J. Mufti, Fabio Ciceri, +12 more
25citations -
Prognostic impact of Epstein-Barr virus serostatus in patients with nonmalignant hematological disorders undergoing allogeneic hematopoietic cell transplantation: the study of Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation2020 Acta Haematologica Polonica article Medicine Hematopoietic Stem Cell Transplantation Open access
Jan Styczyński, Gloria Tridello, Lidia Gil, Per T Ljungman, Małgorzata Mikulska, Steffie Maria van der Werf, +25 more
20citations -
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Köster, Dirk‐Jan Eikema, Anja van Biezen, Friedrich Stölzel, +10 more
12citations -
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT2021 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Stavroula Masouridi‐Levrat, Eduardo Olavarría, Simona Iacobelli, Mahmoud Deeb Aljurf, Еlena V. Morozova, Riitta Niittyvuopio, +18 more
11citations -
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)2023 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access
Guillermo Ortí, Luuk A. Gras, Linda Köster, Alexander Kulagin, Jenny Byrne, Jane F. Apperley, +20 more
9citations -
Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS —a study of the CMWP of the EBMT2023 American Journal of Hematology article Medicine Hematopoietic Stem Cell Transplantation Open access
Alicia Rovó, Luuk A. Gras, Brian Piepenbroek, Nicolaus Martin Kröger, Hans Christian Reinhardt, Aleksandar Radujkovic, +23 more
6citations -
Model-Based Dosing of Anti-Thymocyte Globulin in Pediatric Allogeneic Hematopoietic Cell Transplantation Improves Survival Chances: Updated Results from the Single Arm Phase II Parachute-Trial Combined with Real-World Data2024 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access
Rick Admiraal, Stefan Nierkens, Marc Bierings, Mirjam E. Belderbos, Alwin D. R. Huitema, Robbert G. M. Bredius, +13 more
2citations -
Impact of Post-Transplant Cyclophosphamide (PTCY)-Based Prophylaxis in Matched Sibling Donor Allo-HCT for Patients with Myelodysplastic Syndrome: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
María Queralt Salas, Dirk‐Jan Eikema, Linda Köster, Johan A. Maertens, Jakob Robert Passweg, Jürgen Finke, +18 more
0citations -
MicroRNA-29a Mitigates Osteoblast Senescence and Counteracts Bone Loss through Oxidation Resistance-1 Control of FoxO3 Methylation2021 Antioxidants article Biochemistry, Genetics and Molecular Biology Bone Metabolism and Diseases Open access
Wei‐Shiung Lian, Re‐Wen Wu, Yushan Chen, Jih‐Yang Ko, Holger Jahr, Feng‐Sheng Wang
30citations -
10-day decitabine versus conventional chemotherapy (“3+7”) followed by allografting in AML patients ≥ 60 years: Long-term follow-up results of the randomized phase III trial AML21 of the EORTC leukemia group, GIMEMA and german MDS Study group
Michael Lübbert, Pierre Wijermans, Michal Kiciński, Sylvain Chantepie, Walter J. F. M. van der Velden, Richard Noppeney, +29 more
2citations -
Editorial: Protein post-translational modifications in the nervous system: from development to disease and ageing2024 Frontiers in Molecular Neuroscience editorial Medicine Alzheimer's disease research and treatments Open access
Judit Symmank, Geraldine Zimmer‐Bensch, Miguel Dı́az-Hernández, Patricia Franzka
1citations